| Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna. |
2019-01-02 |
| Promethera Biosciences S.A.. (1/2/19). "Press Release: Promethera Biosciences Announces Investment by Itochu Corporation and a Broad Strategic Collaboration to Access the Asian Markets". Mont-Saint-Guibert & Tokyo. |
2019-01-02 |
| MyoKardia, Inc.. (1/2/19). "Press Release: MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi". South San Francisco, CA. |
2019-01-02 |
| Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2019-01-02 |
| OBN (UK) Ltd.. (1/2/19). "Press Release: OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise". Abingdon. |
2019-01-02 |
| UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY. |
2019-01-03 |
| Bristol-Myers Squibb Company. (1/3/19). "Press Release: Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company". New York, NY & Summit, NJ. |
2019-01-03 |
| ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin. |
2019-01-03 |
| Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. |
2019-01-03 |
| Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim. |
2019-01-03 |
| Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA. |
2019-01-03 |
| Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich. |
2019-01-03 |
| Verily Life Sciences. (1/3/19). "Press Release: Verily Announces $1 Billion Investment Round to Fund Growth and Innovation". South San Francisco, CA. |
2019-01-03 |
| InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY. |
2019-01-03 |
| ICR Inc.. (1/3/19). "Press Release: ICR Acquires Westwicke Partners, North America’s Leading Healthcare-Focused IPO Advisor & Investor Relations Firm". New York, NY. |
2019-01-03 |
| Rentschler Biopharma SE. (1/3/19). "Press Release: Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site". Laupheim & Milford, MA. |
2019-01-03 |
| ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne. |
2019-01-03 |
| Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent. |
2019-01-03 |
| Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. |
2019-01-04 |
| CRISPR Therapeutics AG. (1/4/19). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease". Zug, Cambridge, MA & Boston, MA. |
2019-01-04 |
| Immunocore Ltd.. (1/4/19). "Press Release: Immunocore Appoints Bahija Jallal as Chief Executive Officer". Oxford & Conshohocken, PA. |
2019-01-04 |
| Ribon Therapeutics, Inc.. (1/4/19). "Press Release: Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer". Lexington, MA. |
2019-01-04 |
| Oculis S.A.. (1/4/19). "Press Release: Oculis Raises CHF15.5 Million in an Extension of Its Series B Financing Round – Total Raised CHF35.5 Million". Lausanne. |
2019-01-04 |
| Oculis S.A.. (1/4/19). "Press Release: Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF alpha Antibody Fragment". Lausanne. |
2019-01-04 |
| Boehringer Ingelheim. (1/4/19). "Press Release: Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna". Ingelheim & Cambridge, MA. |
2019-01-04 |
| Medigene AG. (1/4/19). "Press Release: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors". Planegg. |
2019-01-04 |
| BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. |
2019-01-04 |
| BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". |
2019-01-04 |
| Galapagos N.V.. (1/4/19). "Press Release: Fibrocor and Galapagos Sign Partnership in Fibrosis". Mechelen. |
2019-01-04 |
| Biogen Inc.. (1/4/19). "Press Release: Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets". Cambridge, MA & Waltham, MA. |
2019-01-04 |
| Kiadis Pharma N.V.. (1/4/19). "Press Release: Kiadis Pharma Expands Presence in the United States". Amsterdam & Boston, MA. |
2019-01-04 |
| ADC Therapeutics S.A.. (1/4/19). "Press Release: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors". Lausanne. |
2019-01-04 |
| Leerink Partners LLC. (1/4/19). "Press Release: SVB Financial Group Completes Acquisition of Healthcare Investment Bank Leerink Partners". Santa Clara, CA. |
2019-01-04 |
| C4 Therapeutics, Inc.. (1/4/19). "Press Release: Roche Degrader-based Medicines Collaboration. C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche". Watertown, MA. |
2019-01-04 |
| Galapagos N.V.. (1/6/19). "Press Release: Galapagos Initiates NOVESA Phase 2a Trial in Patients with Systemic Sclerosis". Mechelen. |
2019-01-06 |
| Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. |
2019-01-07 |
| Qiagen N.V.. (1/7/19). "Press Release: Qiagen Unveils Plans for Next-generation Digital PCR Systems". Hilden & Germantown, MD. |
2019-01-07 |
| Qiagen N.V.. (1/7/19). "Press Release: Qiagen Acquires N-of-One, Expanding Its Clinical Bioinformatics Capabilities in Molecular Oncology Decision Support". Redwood City, CA & Hilden. |
2019-01-07 |
| AstraZeneca plc. (1/7/19). "Press Release: AstraZeneca Announces Organisational Changes". |
2019-01-07 |
| Immunic AG. (1/7/19). "Press Release: Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company". San Diego, CA & Planegg-Martinsried. |
2019-01-07 |
| 10x Genomics, Inc.. (1/7/19). "Press Release: 10x Genomics Lands New Financing". Pleasanton, CA. |
2019-01-07 |
| Eli Lilly and Company. (1/7/19). "Press Release: Lilly Announces Agreement to Acquire Loxo Oncology". Indianapolis, IN & Stamford, CT. |
2019-01-07 |
| Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company". |
2019-01-07 |
| Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". |
2019-01-07 |
| Alligator Bioscience AB. (1/7/19). "Press Release: Alligator Bioscience Launches RUBY, a Novel Concept in Bispecific Antibody Formats". Lund. |
2019-01-07 |
| Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. |
2019-01-07 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. |
2019-01-07 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. |
2019-01-07 |
| Evotec AG. (1/7/19). "Press Release: Evotec Invests in Financing Round of Exscientia". Hamburg. |
2019-01-07 |
| F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. |
2019-01-07 |
| Keros Therapeutics, Inc.. (1/7/19). "Press Release: Keros Therapeutics Receives $23 Million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases". Lexington, MA. |
2019-01-07 |
| BioMed X GmbH. (1/7/19). "Press Release: Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology". Heidelberg. |
2019-01-07 |
| Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. |
2019-01-07 |
| Foundation Medicine, Inc.. (1/7/19). "Press Release: Foundation Medicine Announces Executive Leadership Transition". Cambridge, MA. |
2019-01-07 |
| Galapagos N.V.. (1/7/19). "Press Release: Galapagos Starts First Phase 1 Trial with Toledo Compound". Mechelen. |
2019-01-07 |
| Aptamer Group Ltd.. (1/7/19). "Press Release: Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices". |
2019-01-07 |
| GreenLight Biosciences, Inc.. (1/8/19). "Press Release: GreenLight Biosciences Announces $50 Million Funding Round". Medford, MA. |
2019-01-08 |
| Calliditas Therapeutics AB. (1/8/19). "Press Release: Calliditas Therapeutics Appoints Andrew Udell to VP Commercial, North America". |
2019-01-08 |
| CureVac AG. (1/8/19). "Press Release: CureVac Announces U.S. Patent Grant for mRNA Vaccination of Infants against RSV". Tübingen & Boston, MA. |
2019-01-08 |
| Galapagos N.V.. (1/8/19). "Press Release: Sands Capital Reports 5.7% Holding in Galapagos". Mechelen. |
2019-01-08 |
| Fluidigm Corporation. (1/8/19). "Press Release: Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring". South San Francisco, CA & Montréal, QC. |
2019-01-08 |
| Genmab A/S. (1/8/19). "Press Release: Genmab Achieves USD 75 Million Sales Milestone in Darzalex (daratumumab) Collaboration with Janssen". Copenhagen. |
2019-01-08 |
| Curetis N.V.. (1/8/19). "Press Release: Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test". Vienna, Amsterdam & Holzgerlingen. |
2019-01-08 |
| c-LEcta GmbH. (1/9/19). "Press Release: c-LEcta Announces Two Long-term Industry Collaborations". |
2019-01-09 |
| Sirion Biotech GmbH. (1/9/19). "Press Release: Sirion Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System". Munich. |
2019-01-09 |
| Selexis S.A.. (1/9/19). "Press Release: Selexis Expands Strategic Immuno-Oncology Alliance with Agenus". Geneva. |
2019-01-09 |
| BC Platforms AG. (1/9/19). "Press Release: BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services". |
2019-01-09 |
| Life Biosciences LLC. (1/9/19). "Press Release: Senolytic Therapeutics Kicks Off Q1 2019 with High-profile Speaking Events Featuring Co-founders Marc Ramis and Manuel Serrano". Boston, MA. |
2019-01-09 |
| Samplix ApS. (1/10/19). "Press Release: Samplix Wins €1.9 Million in Prestigious Horizon 2020 – SME Instrument Program". |
2019-01-10 |
| Formulatrix, Inc.. (1/10/19). "Press Release: Formulatrix Digital PCR Technology to Be Acquired by Qiagen". Bedford, MA. |
2019-01-10 |
| [iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com
and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2019-01-11 |
| Deyton Bell Ltd.. (1/13/19). "Press Release: Deyton Bell Announce Exciting Further Expansion – Harriet Fear Joins the Team". |
2019-01-13 |
| Solentim Ltd.. (1/14/19). "Press Release: Solentim and ATUM Announce Technology Collaboration to Enable Rapid, High Expression, Stable Cell Line Development". Bournemouth. |
2019-01-14 |
| Bioké (Cell Signaling Technology Europe B.V.). (1/14/19). "Press Release: Bioké and OLS Omni Life Science Announce a Distribution Agreement for the BeNeLux Countries". Leiden. |
2019-01-14 |
| Qiagen N.V.. (1/14/19). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Gains Approval in Canada". Germantown, MD & Hilden. |
2019-01-14 |
| Phlexglobal Ltd.. (1/14/19). "Press Release: Phlexglobal Names John McNeill as CEO". Amersham & Malvern, PA. |
2019-01-14 |
| Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement". |
2019-01-14 |
| Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. |
2019-01-15 |
| Minoryx Therapeutics S.L.. (1/15/19). "Press Release: Minoryx Therapeutics Extends Its Activities in Belgium". Mataró, Barcelona & Charleroi. |
2019-01-15 |
| Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. |
2019-01-15 |
| Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris. |
2019-01-15 |
| Immunocore Ltd.. (1/15/19). "Press Release: Immunocore Names David Berman as Head of R&D". Oxford & Conshohocken, PA. |
2019-01-15 |
| InterAx Biotech AG. (1/15/19). "Press Release: InterAx Biotech Closes Financing Round of CHF 3 Million and Appoints New Member of the Board". |
2019-01-15 |
| Life Biosciences LLC. (1/15/19). "Press Release: Life Biosciences Announces Closing of $50 Million Series B Financing Round". Boston, MA. |
2019-01-15 |
| Bioharmony Therapeutics, Inc.. (1/15/19). "Press Release: Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections". New York, NY. |
2019-01-15 |
| Sphere Fluidics Ltd.. (1/15/19). "Press Release: Sphere Fluidics Collaborates with Peak Analysis and Automation to Increase Throughput in Antibody Discovery and Cell Line Development". Cambridge & Farnborough. |
2019-01-15 |
| Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo. |
2019-01-16 |
| Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. |
2019-01-16 |
| High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". |
2019-01-16 |
| Valneva S.E.. (1/16/19). "Press Release: Valneva Announces New $59 Million Ixiaro Supply Contract with US Government". Saint-Herblain. |
2019-01-16 |
| ADC Therapeutics S.A.. (1/16/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors". Lausanne. |
2019-01-16 |
| Agilent Technologies Inc.. (1/16/19). "Press Release: Mala Anand to Join Agilent's Board of Directors". Santa Clara, CA. |
2019-01-16 |
| Merck KGaA. (1/16/19). "Press Release: Merck Welcomes Ten New Startups to Its Innovation Center". Darmstadt. |
2019-01-16 |
| Miltenyi Biotec GmbH. (1/17/19). "Press Release: Miltenyi Biotec Acquires Promising Non-harmful Imaging Process". Bergisch Gladbach. |
2019-01-17 |
| MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. |
2019-01-17 |
| ImaBiotech SAS. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. |
2019-01-17 |
| ImaBiotech SAS. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille. |
2019-01-17 |
| Boehringer Ingelheim. (1/17/19). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Expands Commercial Manufacturing Capacities". Shanghai. |
2019-01-17 |
| BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. |
2019-01-17 |
| Sanofi S.A.. (1/17/19). "Press Release: FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes". Paris & The Woodlands, TX. |
2019-01-17 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
